Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability.
Draulans C, Pos F, Smeenk RJ, Kerkmeijer L, Vogel WV, Nagarajah J, Janssen M, Mai C, Heijmink S, van der Leest M, Zámecnik P, Oyen R, Isebaert S, Maes F, Joniau S, Kunze-Busch M, De Roover R, Defraene G, van der Heide UA, Goffin K, Haustermans K. Draulans C, et al. Among authors: van der heide ua, van der leest m. Pract Radiat Oncol. 2021 May-Jun;11(3):202-211. doi: 10.1016/j.prro.2020.11.006. Pract Radiat Oncol. 2021. PMID: 33941347
Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
Moman MR, van den Berg CA, Boeken Kruger AE, Battermann JJ, Moerland MA, van der Heide UA, van Vulpen M. Moman MR, et al. Among authors: van der heide ua, van vulpen m, van den berg ca. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):741-6. doi: 10.1016/j.ijrobp.2009.02.055. Epub 2009 Oct 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 19804948
Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.
Lips IM, van der Heide UA, Haustermans K, van Lin EN, Pos F, Franken SP, Kotte AN, van Gils CH, van Vulpen M. Lips IM, et al. Among authors: van der heide ua, van lin en, van vulpen m, van gils ch. Trials. 2011 Dec 5;12:255. doi: 10.1186/1745-6215-12-255. Trials. 2011. PMID: 22141598 Free PMC article. Clinical Trial.
Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.
Groenendaal G, Borren A, Moman MR, Monninkhof E, van Diest PJ, Philippens ME, van Vulpen M, van der Heide UA. Groenendaal G, et al. Among authors: van der heide ua, van vulpen m, van diest pj. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e537-44. doi: 10.1016/j.ijrobp.2011.07.021. Epub 2011 Dec 23. Int J Radiat Oncol Biol Phys. 2012. PMID: 22197085
Calibrating page sized Gafchromic EBT3 films.
Crijns W, Maes F, van der Heide UA, Van den Heuvel F. Crijns W, et al. Among authors: van der heide ua, van den heuvel f. Med Phys. 2013 Jan;40(1):012102. doi: 10.1118/1.4771960. Med Phys. 2013. PMID: 23298104
Why prostate tumour delineation based on apparent diffusion coefficient is challenging: an exploration of the tissue microanatomy.
Borren A, Moman MR, Groenendaal G, Boeken Kruger AE, van Diest PJ, van der Groep P, van der Heide UA, van Vulpen M, Philippens ME. Borren A, et al. Among authors: van der groep p, van der heide ua, van vulpen m, van diest pj. Acta Oncol. 2013 Nov;52(8):1629-36. doi: 10.3109/0284186X.2013.787164. Epub 2013 Apr 28. Acta Oncol. 2013. PMID: 23621751
221 results